Telomerase and drug resistance in cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Telomerase activity is altered in cancer cells.
• Reduced telomerase expression/activity correlates with increased sensitivity to chemotherapy drugs like doxorubicin, cisplatin, and 5-fluorouracil.
• The precise mechanisms underlying this observed drug resistance remain largely unknown.

Purpose of the Study:

• To review current theories on the role of telomerase in cancer cell drug resistance.
• To elucidate the complex relationship between telomerase alterations and resistance to cancer therapies.
• To highlight the potential for improved cancer treatment strategies by understanding this correlation.

Main Methods:

• Literature review of existing research on telomerase and cancer drug resistance.
• Analysis of proposed mechanisms including telomere shortening, genomic instability, hTERT translocation, mitochondrial function, and ABC gene expression.
• Synthesis of current knowledge to identify gaps and future research directions.

Main Results:

• Several theories link telomerase alterations to drug resistance, involving factors like telomere length, genome stability, and cellular metabolism.
• Mechanisms such as hTERT translocation and altered ABC transporter expression are proposed but not fully understood.
• The precise molecular pathways connecting telomerase status to drug response in cancer cells require further investigation.

Conclusions:

• Understanding the role of telomerase in cancer drug resistance is crucial for developing more effective cancer therapies.
• Targeting telomerase or exploiting its altered activity could enhance the elimination of drug-resistant cancer cells.
• Further research is needed to fully unravel the multifaceted mechanisms involved in telomerase-mediated drug resistance.